United States · 
What does AMR Action Fund invest in?
AMR Action Fund invests most often at Series A (100% of the rounds on record), in sectors such as Health-tech, Well-being and Ehealth.
AMR Action Fund highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Series A: 100% of its rounds
- 03
Sole investor in 1 rounds, median $9.0M
What they do
We Invest... In biotechnology companies that are developing treatments for patients suffering from life-threatening antimicrobial-resistant infections.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- Series ASeries BGrowth
- Sectors
- Health-techWell-beingEhealth
- Based in
- Boston, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2026
2 rounds
- Jul
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
DCDavid Christopher HellmuthChief Compliance Officer, General Counsel and Chief Operating OfficeriForm ADV
HBHenry Bradford SkinnerChief Executive OfficeriForm ADV
JWJohn William VancuraChief Financial OfficeriForm ADV
MHMartin HeideckerChief Investment OfficeriForm ADV
We also hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$977Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- AMR Action Fund GP, LLC
- SEC number
- CRD 335963
What they claim to have backed
From their own portfolio page (on their website)
6 of 9 we have independently watched raise
AntabioCentauritherapeuticsF2gPeptilogicsTelumtherapeuticsVedantabioBioversysPatternTrellisbio
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.